Gennate

Investor: SFC Capital

Gennate, a developer of next-generation plant nutrition nanomaterials, has successfully completed a £550,000 seed funding round. The investment was led by SFC Capital, with additional participation from the GM Advance Fund and the Salonica Infinity Fund.Summary of transaction details:Value: £550,000Sector: Healthcare & BiotechAdvisor: N/AKey Entities: Gennate (Target), SFC Capital, GM Advance Fund, Salonica Infinity Fund (Investors)Location: Stockport, UK (with laboratory space at Manchester Science Park)Note: This funding is intended to support the creation of up to 15 new jobs and underpin the continued development and expansion of Gennate's innovative nanomaterials technology.